author-photo

Hui Zhao

Anhui University

3

Papers

12

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Progression pattern and post-progression treatment of furmonertinib (AST2818) in EGFR T790M mutation positive NSCLC patients: A post-hoc analysis from a multicenter, single-arm study.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study.

2021 The Lancet Respiratory Medicine
Show All
- Source
- Cite
- Save
Citations (6)